Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse

被引：22

作者：

Bigini, Paolo ^{[1
]}

Repici, Mariaelena ^{[2
]}

Cantarella, Giuseppina ^{[3
]}

Fumagalli, Elena ^{[1
]}

Barbera, Sara ^{[1
]}

Cagnotto, Alfredo ^{[1
]}

De Luigi, Ada ^{[1
]}

Tonelli, Rossella ^{[1
]}

Bernardini, Renato ^{[3
]}

Borsello, Tiziana ^{[2
,4
]}

Mennini, Tiziana ^{[1
]}

机构：

[1] Inst Rich Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy

[2] Univ Lausanne, DBCM, CH-1005 Lausanne, Switzerland

[3] Univ Catania, Dept Expt & Clin Pharmacol, I-95125 Catania, Italy

[4] Inst Rich Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy

来源：

NEUROBIOLOGY OF DISEASE | 2008年 / 29卷 / 03期

关键词：

TNFR1; rhTBP-1; p38MAPK; JNK; motor neuron degeneration; wobbler; amyotrophic lateral sclerosis; TNF-alpha; glial activation;

D O I：

10.1016/j.nbd.2007.11.005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

TNF-alpha overexpression may contribute to motor neuron death in amyotrophic lateral sclerosis (ALS). We investigated the intracellular pathway associated with TNF-alpha in the wobbler mouse, a murine model of A LS, at the onset of symptoms. TNF-alpha and TNFR1 overexpression and JNK/p38MAPK phosphorylation occurred in neurons and microglia in early symptomatic mice, suggesting that this activation may contribute to motor neuron damage. The involvement of TNF-alpha was further confirmed by the protective effect of treatment with rhTNF-alpha. binding protein (rhTBP-1) from 4 to 9 weeks of age. rhTBP-1 reduced the progression of symptoms, motor neuron loss, gliosis and JNK/ p38MAPK phosphorylation in wobbler mice, but did not reduce TNF-alpha and TNFR1 levels. rhTBP-1 might possibly bind TNF-alpha and reduce the downstream phosphorylation of two main effectors of the neuroinflammatory response, p38MAPK and JNK. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：465 / 476

页数：12

共 47 条

[11] Onset and progression in inherited ALS determined by motor neurons and microglia [J].

Boillee, Severine ;

Yamanaka, Koji ;

Lobsiger, Christian S. ;

Copeland, Neal G. ;

Jenkins, Nancy A. ;

Kassiotis, George ;

Kollias, George ;

Cleveland, Don W. .

SCIENCE, 2006, 312 (5778) :1389-1392

[12] Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].

Bonny, C ;

Oberson, A ;

Negri, S ;

Sauser, C ;

Schorderet, DF .

DIABETES, 2001, 50 (01) :77-82

[13] A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].

Borsello, T ;

Clarke, PGH ;

Hirt, L ;

Vercelli, A ;

Repici, M ;

Schorderet, DF ;

Bogousslavsky, J ;

Bonny, C .

NATURE MEDICINE, 2003, 9 (09) :1180-1186

[14]

Cahill MA, 1996, ONCOGENE, V13, P2087

[15] TUMOR-NECROSIS-FACTOR-ALPHA INDUCES SUBSTANCE-P IN SYMPATHETIC-GANGLIA THROUGH SEQUENTIAL INDUCTION OF INTERLEUKIN-1 AND LEUKEMIA INHIBITORY FACTOR [J].

DING, MZ ;

HART, RP ;

JONAKAIT, GM .

JOURNAL OF NEUROBIOLOGY, 1995, 28 (04) :445-454

[16] Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: Opposite roles of TNF receptor 1 and TNF receptor 2 [J].

Fontaine, V ;

Mohand-Said, S ;

Hanoteau, N ;

Fuchs, L ;

Pfizenmaier, K ;

Eisel, U .

JOURNAL OF NEUROSCIENCE, 2002, 22 (07)

[17] Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease [J].

Fumagalli, E ;

Bigini, P ;

Barbera, S ;

De Paola, M ;

Mennini, T .

EXPERIMENTAL NEUROLOGY, 2006, 198 (01) :114-128

[18] Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve [J].

George, A ;

Buehl, A ;

Sommer, C .

EXPERIMENTAL NEUROLOGY, 2005, 192 (01) :163-166

[19] Tumor necrosis factor and motoneuronal degeneration: An open problem [J].

Ghezzi, P ;

Mennini, T .

NEUROIMMUNOMODULATION, 2001, 9 (04) :178-182

[20] Absence of tumor necrosis factor-α does not affect motor neuron disease caused by superoxide dismutase 1 mutations [J].

Gowing, Genevieve ;

Dequen, Florence ;

Soucy, Genevieve ;

Julien, Jean-Pierre .

JOURNAL OF NEUROSCIENCE, 2006, 26 (44) :11397-11402

← 1 2 3 4 5 →